InvestorsObserver is giving Idera Pharmaceuticals Inc (IDRA) an Analyst Rating Rank of 4, meaning IDRA is ranked higher by analysts than 4% of stocks. The average price target for IDRA is $2 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating IDRA a Hold today. Find out what this means to you and get the rest of the rankings on IDRA!
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With Idera Pharmaceuticals Inc Stock Today?
Idera Pharmaceuticals Inc (IDRA) stock is trading at $1.06 as of 10:37 AM on Wednesday, Sep 8, a decline of -$0.01, or -0.93% from the previous closing price of $1.07. The stock has traded between $1.06 and $1.08 so far today. Volume today is less active than usual. So far 72,562 shares have traded compared to average volume of 510,812 shares.
Click Here to get the full Stock Report for Idera Pharmaceuticals Inc stock.